Low-Dose Edoxaban for Stroke Prevention in Elderly Patients with Atrial Fibrillation: Comment on the Edoxaban Low-Dose for Elder Care Atrial Fibrillation Patients (ELDERCARE-AF) Trial

Results of the ELDERCARE-AF trial have been presented at the ESC Congress 2020 and simultaneously published in theNew England Journal of Medicine (https://doi.org/10.1056/NEJMoa2012883).
Source: European Heart Journal - Category: Cardiology Source Type: research